Viatris Inc. (VTRS)
NASDAQ: VTRS · Real-Time Price · USD
8.96
+0.19 (2.17%)
At close: May 12, 2025, 4:00 PM
8.97
+0.01 (0.11%)
After-hours: May 12, 2025, 7:25 PM EDT
Viatris Employees
Viatris had 32,000 employees as of December 31, 2024. The number of employees decreased by 6,000 or -15.79% compared to the previous year.
Employees
32,000
Change (1Y)
-6,000
Growth (1Y)
-15.79%
Revenue / Employee
$447,819
Profits / Employee
-$118,441
Market Cap
10.52B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
VTRS News
- 4 days ago - Viatris Discloses Positive Data From 2 Drugs In Earnings Report, Stock Soars - Benzinga
- 4 days ago - Viatris Q1 Earnings Review: Shares Are Up, Time To Sell (Rating Downgrade) - Seeking Alpha
- 4 days ago - Viatris Inc. (VTRS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Viagra-maker Viatris beats quarterly estimates on demand for branded drugs in China - Reuters
- 4 days ago - Viatris Reports First Quarter 2025 Results and Reaffirms 2025 Outlook - PRNewsWire
- 4 days ago - Viatris Announces Positive Results from Phase 3 Study of Investigational XULANE LO™ Low Dose Patch for Birth Control in Women of Childbearing Potential - PRNewsWire
- 4 days ago - Viatris' pain drug meets main goals of two late-stage trials - Reuters
- 4 days ago - Viatris Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of Novel Fast-Acting Meloxicam (MR-107A-02) for the Treatment of Moderate-to-Severe Acute Pain - PRNewsWire